卵磷脂片治疗阿尔茨海默病的临床效果

Abstract
Figure/Table
References (21)
Related Citation (15)

Download: PDF (0 KB) HTML (36 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To evaluate the efficacy of Lecithin Tablets in the treatment of mild and moderate Alzheimer′s disease(AD).Methods A total of 118 patients with mild to moderate AD admitted to the First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine from January 2019 to January 2020 were selected and divided into observation group and control group according to the random number table method,with 59 cases in each group.The control group received conventional treatment,and the observation group received Lecithin Tablets treatment on the basis of the control group.Both groups received continuous medication for 12 weeks.The clinical efficacy of the two groups was observed and compared,the clinical memory scale was used to evaluate and compare the memory scores of the two groups,the ability of daily living(ADL)was used to assess and compare the ability of daily living of the two groups,and the dementia deficit scale(ADS)was used to evaluate and compare the two Group dementia degree,observe and compare the occurrence of adverse reactions between the two groups.Results The total effective rate of treatment in the observation group was higher than that in the control group,and the difference was statistically significant(P＜0.05).Before treatment,there was no significant difference in the scores of the clinical memory scales between the two groups(P＞0.05);after 12 weeks of treatment,the clinical memory scale scores of the observation group were higher than those before the treatment,the differences were statistically significant(P＜0.05).After 6 and 12 weeks of treatment,the ADL and ADS scores of the two groups were lower than those of before treatment,and the observation group was lower than that of the control group in the same period,the differences were statistically significant(P＜0.05).There were no abnormal findings in the laboratory liver and kidney functions and the three major routine examinations before and after treatment in the two groups.Conclusion It had certain clinical effect on Lecithin Tablets in the treatment of mild and moderate AD,and the clinical memory scale,ADL and ADS scores have been effectively improved,which has certain security.

Key words： Lecithin Alzheimer&prime s disease Clinical effects

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIU Zheng
	LIU Bo-wen

Cite this article:

LIU Zheng,LIU Bo-wen. Clinical effect of Lecithin Tablets in the treatment of Alzheimer′s disease[J]. 中国当代医药, 2021, 28(13): 92-95.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I13/92

[1]	陈刚，曹雯炜，俞羚，等.最新AD 研究用诊断标准：IWG-2标准[J].神经病学与神经康复学杂志，2014，11（3）：133-143.
[2]	李伟，肖世富.阿尔茨海默病诊断标准的演变及评价[J].中华诊断学电子杂志，2015，3（2）：114-117.
[3]	吕艳，张增强，王海，等.海南版简易智能状态检查量表和蒙特利尔认知评估量表界值划分的初步研究[J].中华老年心脑血管病杂志，2020，22（4）：352-355.
[4]	姚培芬，肖世富，严和骎.阿尔茨海默病不同严重程度的临床神经心理学研究[J].上海精神医学，2004，16（1）：156-158.
[5]	简文佳，时晶，倪敬年，等.日常生活能力量表鉴别痴呆与轻度认知损害[J].中国老年学杂志，2014，34（4）：865-868.
[6]	龙子弋.基于证候要素的痴呆证候分型量表研究[D].北京：北京中医药大学，2012.
[7]	钟春玖.阿尔茨海默病研究现状、启示和未来趋势[J].阿尔茨海默病及相关病杂志，2020，3（2）：91-95，89.
[8]	张燕，陈洪，于伟.阿尔兹海默病的Aβ 蛋白病理新探索[J].吉林医学，2015，36（1）：115-116.
[9]	郭敏，李树民，张弘，李刚.阿尔兹海默病的表观遗传学机制研究进展[J].中国临床药理学杂志，2014，30（3）：232-234.
[10]	王晓珍，王蓉.阿尔茨海默病的药物治疗及研发进展[J].中国新药杂志，2019，28（24）：2960-2964.
[11]	周慧荣.脑内乙酰胆碱与认知活动关系的探析[J].中国现代药物应用，2013，7（11）：68-69.
[12]	张亦红，程华，孙兴斌.卵磷脂改善记忆的动物实验研究[J].营养学报，2002，34（4）：435-436.
[13]	池莉平，朱展鹰，黄俊明，等.大豆卵磷脂改善记忆作用动物实验研究[J].中国热带医学，2006，（11）：1945-1946.
[14]	张晓辉.多烯磷脂酰胆碱对于阿尔茨海默病治疗作用的研究[D].西安：第四军医大学，2011.
[15]	李彬.如何预防突发性心脑血管病——单独补充卵磷脂的必要性[J].养生大世界，2009，（5）：48.
[16]	李彬.卵磷脂与纳豆，谁是防治心脑血管病的“真英雄”?——世界卫生组织强调卵磷脂是清洗血管的根本[J].养生大世界，2010，（4）：43.
[17]	李彬.大脑思维的原动力——卵磷脂[J].养生大世界，2006，（6）：62.
[18]	陈谅.Alzheimer 型痴呆与脑内乙酰胆碱能神经元[J].国外医学.精神病学分册，1984，（4）：201-204.
[19]	田金洲，时晶，张学凯，等.2011年美国阿尔茨海默病最新诊断标准解读[J].中国医学前沿杂志（电子版），2011，3（4）：91-100.
[20]	李振光，张金彪，孙海荣.帕金森病患者血浆磷脂含量变化及其与轻度认知功能障碍的关系[A].中华医学会（Chinese Medical Association）、中华医学会神经病学分会（Chinese Society of Neurology）.第四届全国痴呆与认知障碍学术研讨会及高级讲授班论文汇编[C].中华医学会（Chinese Medical Association）、中华医学会神经病学分会（Chinese Society of Neurology）：中华医学会，2015：1.
[21]	叶心国，李涛，李承晏.帕金森病伴发认知障碍患者血浆磷脂含量变化及意义[J].实用老年医学，2016，30（10）：840-843.